<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    IMAC Holdings, Inc.

    IMAC Holdings, Inc.

    IMAC Holdings, Inc. owns or manages IMAC Regeneration Centers, which combine life ...

    IMAC Holdings, Inc. owns or manages IMAC Regene...

    Filing Type:    PU
    Kezar Life Sciences, Inc.

    Kezar Life Sciences, Inc.

    Based in South San Francisco, we are a clinical-stage biotechnology company commit...

    Based in South San Francisco, we are a clinical...

    Filing Type:    PU
    Zimmerman BioPharma Holding, Inc.

    Zimmerman BioPharma Holding, Inc.

    ZBP is a biopharmaceutical company that has developed a proprietary technology to ...

    ZBP is a biopharmaceutical company that has dev...

    Fundraising Status:    EC
    Filing Type:    RA
    Aptose Biosciences, Inc.

    Aptose Biosciences, Inc.

    Aptose Biosciences is a clinical-stage biotechnology company developing personaliz...

    Aptose Biosciences is a clinical-stage biotechn...

    Filing Type:    PU
    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical is a specialty pharmaceutical company committed to being ...

    Collegium Pharmaceutical is a specialty pharmac...

    Filing Type:    PU
    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on ...

    Bellicum Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    Genprex, Inc.

    Genprex, Inc.

    Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in ...

    Genprex Inc is a U.S.-based clinical-stage gene...

    Filing Type:    PU
    Clovis Oncology, Inc.

    Clovis Oncology, Inc.

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnolog...

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS)...

    Filing Type:    PU
    ArQule, Inc.

    ArQule, Inc.

    ArQule is a biopharmaceutical company engaged in the research and development of t...

    ArQule is a biopharmaceutical company engaged i...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.